Monoclonal Antibodies in Veterinary Health: Global and Regional Market Analysis by Animal Type, Application, End User, and Country - Forecast to 2033
March 18, 2024 05:49 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies in Veterinary Health Market: Focus on Animal Type, Application, and End User, Regional Analysis, and Competitive...
Global Therapeutic Antibody Market Research, 2019-2023 and 2024-2029
February 27, 2024 10:04 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human,...
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
February 21, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced...
Downstream Processing Market Report 2024: Global Trends and Competitive Analysis to 2030 Featuring Thermo Fisher Scientific, GE Healthcare, Sartorius, Merck Millipore, Danaher, and 3M Among Others
February 21, 2024 06:37 ET
|
Research and Markets
Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Downstream Processing Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Global IL-17 Biologics Research Report 2023-2030: A $4.37 Billion Market in 2022 - Advancements in Monoclonal Antibody Engineering Fuel Development of Targeted IL-17 Biologics
February 20, 2024 10:57 ET
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By...
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
February 13, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences®...
Biologic Therapeutic Drugs Market Analysis Reveals Robust Growth Projections Through 2028, Discloses Technologies and Global Markets Insights
February 09, 2024 04:16 ET
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Biologic Therapeutic Drugs: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The biologics market is...
Global Biosimilars and Biologics Market Surges: $46.11 Billion Market Forecast for 2028 - Industry Trends and Strategic Analysis
February 02, 2024 10:43 ET
|
Research and Markets
Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimilars and Biologics Market (2023-2028) by Product, Application, and Geography, Competitive Analysis, Impact of Covid-19, Ansoff Analysis"...
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Industry Forecast to 2032: U.S. Projected to Maintain Dominance, Driven by Innovative Therapies Entering the Market
January 30, 2024 07:43 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) - Market Insights, Epidemiology, and Market Forecast - 2032" report has been added to ...
Biologics Testing Global Market Report 2024: Rapid Growth Projected Due to Asian-Pacific Expansion and Technological Innovations - Long-term Forecasts to 2028 and 2033
January 25, 2024 07:42 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Biologics Testing Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Biologics Testing Industry Analysis...